October 4, 2012 - When the recall of the popular Stryker Rejuvenate and ABG II hip implants was announced on July 6, 2012, more than 20,000 patients who had received the devices since 2010 were affected.
Now, those who are seeking help for future medical costs are even more frustrated to learn that the company knew of the dangers of their hip devices for months or even years before the recall, but did little to warn patients.
In April of 2012, Stryker issued an “Urgent Field Safety Notice” to implant surgeons and hospital risk managers advising that the Rejuvenate and ABG II hip implants could experience corrosion and fretting from wear, sending tiny metal shards into patients’ tissues, bones and bloodstream.
September 28, 2012 - When the Stryker Rejuvenate and ABG II hip replacement devices were released in 2010, they were heralded as an innovative design that would give implant patients a better, more natural fit, with a durable device life.
However, data from the FDA now suggests that these devices, which have since been recalled, were rushed to market to boost sales without proper testing or warnings to patients about the inherent risks.
Studies have shown that modern metal-on-metal hip implants can experience corrosion and fretting from wear between metal components, sending tiny metal shards into patients’ tissues, bones and bloodstream. With the four-part construction of the Stryker hips, the possibility for wear is heightened.
June 21, 2012 - The Maker of Yaz and Yasmin, Bayer Pharmaceuticals, has announced it has begun settling some of the approximately 11,000 Yaz lawsuits filed by women suffering severe side effects.
However, it is important to understand that only some cases may be settled and any victim should select a reputable law firm to make sure their case is handled properly.
In 2009, The British Medical Journal published studies from Denmark and the Netherlands linking the chemicals in Yaz to blood clots. In October, 2011 the FDA also released data of more than 825,000 women taking oral contraceptives which showed drugs like Yaz could cause up to a 74% increased risk of developing blood clots.
June 6, 2012 – Those women who took the birth control drugs Yaz or Yasmin and suffered side effects are being alerted of a new court order which will allow more time for them to get a Yaz settlement.
Anyone who experienced a blood clot, DVT, stroke or pulmonary embolism after taking Yaz should speak with a qualified lawyer immediately to learn what rights they have and what compensation is available.
Legal action started after studies from Denmark and the Netherlands in 2009 linked Yaz to blood clots. In October, 2011 the FDA also released a study of more than 825,000 women showing drugs like Yaz could cause up to a 74% increased risk of developing blood clots.